Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
14-17 October, 2024
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
15-17 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
14-17 October, 2024
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
15-17 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-have-built-considerable-expertise-in-glp-1-drug-development-through-our-oral-peptide-programs
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-europe-turn-to-advanced-manufacturing-stockpiling-to-strengthen-drug-supply-chains
06 Dec 2022
// INDIANPHARMAPOST
https://www.indianpharmapost.com/news/lonzas-api-manufacturing-facility-expansion-in-nansha-starts-commercial-operation-13396
01 Dec 2022
// Lucy Chard CPHI-ONLINE
https://www.cphi-online.com/pharma-supply-chain-people-moves-news110006.html
12 Sep 2022
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2022-09-12/lonza-appoints-daniel-palmacci-as-president-of-cell-gene-division/?widget=listSection
01 Sep 2022
// Jenni Spinner OUTSOURCING-PHARMA
https://www.outsourcing-pharma.com/Article/2022/09/01/lonza-expanding-dry-powder-inhalation-capabilities-at-florida-site
23 Aug 2022
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2022-08-22/lonza-introduces-x[…]fraction-capability-at-monteggio-site/?widget=listSection
04 Aug 2022
// CLEANROOMTECHNOLOGY
https://www.cleanroomtechnology.com/news/article_page/Lonza_debuts_first_multimode_reader_to_streamline_quantitative_endotoxin_detection/202685
Services
Analytical
Pharma Service : Analytical
Category : Stability Studies
Sub Category : Overview
Pharma Service : Analytical
Pharma Service : Analytical
Category : Analytical Method Development
Sub Category : Method Development and Validation
Pharma Service : Analytical
Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Category : Raw Materials
Sub Category : Empty Capsules
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Category : Capsule
Sub Category : Hard Capsule
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Category : Capsule
Sub Category : Immediate Release
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Category : Capsule
Sub Category : Immediate Release
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Category : Capsule
Sub Category : Clinical Supply
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Capsule
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Clinical Supply
Pharma Service : API & Drug Product Development
Clinical Trials
Excipients
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3367
Submission : 1978-11-08
Status : Active
Type : IV
Registration Number : 220MF40002
Registrant's Address : Kanagawa Prefecture Sagamihara City Chuo Ward Minami Hashimoto 4-3-36
Initial Date of Registration : 2008-09-19
Latest Date of Registration :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3940
Submission : 1980-09-18
Status : Active
Type : IV
Registration Number : 220MF40001
Registrant's Address : Kanagawa Prefecture Sagamihara City Chuo Ward Minami Hashimoto 4-3-36
Initial Date of Registration : 2008-03-18
Latest Date of Registration :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3943
Submission : 1980-09-02
Status : Active
Type : IV
Registration Number : 217MF40001
Registrant's Address : Kanagawa Prefecture, Sagamihara City, Chuo Ward, Minami Hashimoto 4-3-36
Initial Date of Registration : 2005-08-23
Latest Date of Registration :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24010
Submission : 2010-07-27
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12731
Submission : 1997-10-27
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15660
Submission : 2001-10-09
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17242
Submission : 2004-03-05
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21685
Submission : 2008-06-06
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21784
Submission : 2008-07-11
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22635
Submission : 2009-03-17
Status : Active
Type : IV
Excipients by Ingredients
Dosage Form : Clinical Supply
Grade : Oral
Application : Empty Capsules
Excipient Details : DBcaps® capsules are developed with a tamper-evident design to specifically address the clinical trial challenges of testing without bias.
Pharmacopoeia Ref : Not Available
Technical Specs : Size # AAA- E
Ingredient(s) : Gelatin, Unspecified; Hydroxypropyl Methyl Cellulose
Dosage Form : HardGel
Grade : Oral
Application : Empty Capsules
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Gelatin, Unspecified; Hydroxypropyl Methyl Cellulose
Dosage Form : Inhalation
Grade : Inhalation
Application : Empty Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : Size # 00el - 4
Ingredient(s) : Gelatin, Unspecified; Hydroxypropyl Methyl Cellulose
Excipients By applications
Inspections and registrations
District Decision : No Action Indicated
Inspection End Date : 2019-04-23
City : Morristown
State : NJ
Country/Area : US
Zip : 07960-6674
District : NWJ
Center : CFSAN
Project Area : Foodborne Biological Hazards
District Decision : No Action Indicated
Inspection End Date : 2019-04-23
District Decision : Voluntary Action Indicated
Inspection End Date : 2010-02-17
City : Ploermel
State :
Country/Area : FR
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2010-02-17
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-30
City : Ploermel
State :
Country/Area : FR
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-30
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-04-20
City : Ploermel
State :
Country/Area : FR
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-04-20
District Decision : No Action Indicated
Inspection End Date : 2014-04-02
City : Visp
State :
Country/Area : CH
Zip :
District : ORA
Center : CFSAN
Project Area : Food Composition, Standards, Lab...
District Decision : No Action Indicated
Inspection End Date : 2014-04-02
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-03-10
City : Singapore
State :
Country/Area : SG
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-03-10
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-05-30
City : Braine-l\\\'alleud
State :
Country/Area : BE
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-05-30
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-08-29
City : Visp
State :
Country/Area : CH
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-08-29
District Decision : No Action Indicated
Inspection End Date : 2014-04-02
City : Visp
State :
Country/Area : CH
Zip :
District : ORA
Center : CFSAN
Project Area : Foodborne Biological Hazards
District Decision : No Action Indicated
Inspection End Date : 2014-04-02
District Decision : No Action Indicated
Inspection End Date : 2013-11-07
City : Guangzhou
State :
Country/Area : CN
Zip :
District : ORA
Center : CFSAN
Project Area : Foodborne Biological Hazards
District Decision : No Action Indicated
Inspection End Date : 2013-11-07
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?